Cardiff Oncology Inc (CRDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 141 | 108 | 83 | 128 | 93 |
| Gross Profit | 141 | 108 | 83 | 128 | 93 |
| Operating Expenses | 10,961 | 12,316 | 12,135 | 9,520 | 9,086 |
| Operating Income | -10,820 | -12,208 | -12,052 | -9,392 | -8,993 |
| Other Income | 1,089 | 1,058 | 829 | 695 | 422 |
| Pre-tax Income | -9,731 | -11,150 | -11,223 | -8,697 | -8,571 |
| Net Income Continuous | -9,731 | -11,150 | -11,223 | -8,697 | -8,571 |
| Net Income | $-9,731 | $-11,150 | $-11,223 | $-8,697 | $-8,571 |
| EPS Basic Total Ops | -0.22 | -0.25 | -0.25 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | -0.22 | -0.25 | -0.25 | -0.19 | -0.20 |
| EPS Diluted Total Ops | -0.22 | -0.25 | -0.25 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | -0.22 | -0.25 | -0.25 | -0.19 | -0.20 |
| EBITDA(a) | $-11,024 | $-12,352 | $-12,125 | $-9,346 | $-8,797 |